We used an anti-PD-1 antibody to verify the hypothesis that inhibition of the PD-1/B7H1 pathway can mediate a therapeutic effect in an orthotopic glioma stem-like cells mouse model. This evidence concerns the gene PDCD1 and central nervous system cancer.